Furthermore, RCC patients with high expression levels of EpoR in the kidney tissues and high serum Epo (s-Epo) concentrations (>30 mU/ml) had better 5-year survival rates than those with low EpoR levels and s-Epo concentrations (24). This evidence concerns the gene EPOR and renal cell carcinoma.